Asia-Pacific Biotech News

Rockeby Biomed Cancel Agreement to Supply Test Kits to Turkish Poultry Industry.

India Launches Healthcare Drive.

Japan's Eisai Company Says 11 Die in Alzheimer's Drug Trial.

Innovation Dynamics to Set up Office in Perth.

Millipore India Sets up EOU to Manufacture Purification Systems for Global Markets.

Life Therapeutics to Spin Out Two Divisions into a New Company.

GSK to Build Vaccine Facility in Taiwan.

H5N1 Bird Flu has Evolved into Two Strains.

Biocon to be Investigated for Drug Violations.

Biometrics and E-Authentication.

Biometrics for Inanimate Objects: The Emergence of Commercially Viable 'Materiametrics'.

Australian Drug Discovery Company, Incitive Ltd, Announces Initial Public Offer.

Biosignal Collaborates with Ciba Specialty Chemicals.

Brisbane's Tissue Therapy Partners Canada's QSV Biologics.

Cellestis Signs Agreements on TB and Cytomegalovirus with FIND.

Mesoblast Obtained an Exclusive Worldwide License to Commercialize New Drug-eluting Stent Technology.

Narhex Life Sciences Ltd: An Emerging Australian Biotechnology Company.

Norwood Immunology Collaborates with Australian Stem Cell Center and Monash University.

Premier Bionics' Subsidiary Medic Vision Team up with the University of Melbourne and the CSIRO.

PharmaEng signs LOI to Purchase Beijing Lixin PharmaTech.

Japan's Bioventures Today—Noas Medical Co Ltd.

Singapore Heart, Stroke and Cancer Center Conducts Research on CT Coronary Angiogram.

Singapore's TCM Practitioner Board Sets up New Guidelines on Ethical Conduct.